Abstract
Apolipoprotein E (APOE) is implicated not only in chronic degenerative neurological diseases, such as Alzheimer's disease, but also in acute brain disorders, including traumatic brain injury. Bexarotene, a selective agonist of the retinoid X receptor, has been reported to enhance markedly the expression of APOE. Previous studies have indicated that bexarotene exerts neuroprotective effects in animal models of ischemic stroke by modulating the peripheral immune response and autophagy. However, the role of this drug in neuronal apoptosis and the potential mechanisms involved have yet to be elucidated. The present study employed transient middle cerebral artery occlusion (t-MCAO) as a model of acute cerebral ischemia/reperfusion injury. The experiments were performed in wild-type C57BL/6 mice and APOE gene knockout (APOE-KO) mice. After t-MCAO, mice received intraperitoneal injection of bexarotene (5 mg/kg) or an equal volume of the vehicle. The outcome measurements included neurological deficits, learning ability, spatial memory, infarct volume, histopathology, magnitude of apoptosis, and the level of expression of proteins of the JNK/caspase-3 signaling pathway. The obtained results demonstrated that bexarotene administration significantly improved neurological function, learning ability, and spatial memory in C57BL/6 mice, but not in APOE-KO mice. Infarct volume, tissue damage, neuronal apoptosis rate, and the expression of proteins involved in the JNK/caspase-3 signaling pathway were markedly increased after t-MCAO in both C57BL/6 and APOE-KO mice. Importantly, bexarotene treatment significantly ameliorated all these changes in C57BL/6, but not in APOE-KO mice. In conclusion, bexarotene markedly alleviates the neurological deficits, improves the histological outcome, and inhibits cell apoptosis in mice after t-MCAO. This effect is mediated, at least in part, by up-regulation of APOE. Thus, bexarotene may be a candidate drug for the treatment of cerebral ischemia patients.
Similar content being viewed by others
Reference
Flynn RW, MacWalter RS, Doney AS (2008) The cost of cerebral ischaemia. Neuropharmacology 55:250–256
Fonarow GC, Reeves MJ, Zhao X, Olson DM, Smith EE, Saver JL, Schwamm LH, Get With the Guidelines-Stroke Steering Committee and Investigators (2010) Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation 121:879–891
Huuskonen MT, Loppi S, Dhungana H, Keksa-Goldsteine V, Lemarchant S, Korhonen P, Wojciechowski S, Pollari E, Valonen P, Koponen J, Takashima A, Landreth G, Goldsteins G, Malm T, Koistinaho J, Kanninen KM (2016) Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy. Sci Rep 6:33176
Xu L, Cao F, Xu F, He B, Dong Z (2015) Bexarotene reduces blood-brain barrier permeability in cerebral ischemia-reperfusion injured rats. PLoS ONE 10:e0122744
Lynch JR, Morgan D, Mance J, Matthew WD, Laskowitz DT (2001) Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J Neuroimmunol 114:107–113
Lomnitski L, Chapman S, Hochman A, Kohen R, Shohami E, Chen Y, Trembovler V, Michaelson DM (1999) Antioxidant mechanisms in apolipoprotein E deficient mice prior to and following closed head injury. Biochim Biophys Acta 1453:359–368
Zhou S, Wu H, Zeng C, Xiong X, Tang S, Tang Z, Sun X (2013) Apolipoprotein E protects astrocytes from hypoxia and glutamate-induced apoptosis. FEBS Lett 587:254–258
Osada N, Kosuge Y, Kihara T, Ishige K, Ito Y (2009) Apolipoprotein E-deficient mice are more vulnerable to ER stress after transient forebrain ischemia. Neurochem Int 54:403–409
Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335:1503–1506
McFarland K, Spalding TA, Hubbard D, Ma JN, Olsson R, Burstein ES (2013) Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson's disease. ACS Chem Neurosci 4:1430–1438
Riancho J, Ruiz-Soto M, Berciano MT, Berciano J, Lafarga M (2015) Neuroprotective effect of bexarotene in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9:250
Tunctan B, Kucukkavruk SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S (2018) Bexarotene, a selective RXRalpha agonist, reverses hypotension associated with inflammation and tissue injury in a rat model of septic shock. Inflammation 41:337–355
Certo M, Endo Y, Ohta K, Sakurada S, Bagetta G, Amantea D (2015) Activation of RXR/PPARgamma underlies neuroprotection by bexarotene in ischemic stroke. Pharmacol Res 102:298–307
Zhong J, Cheng C, Liu H, Huang Z, Wu Y, Teng Z, He J, Zhang H, Wu J, Cao F, Jiang L, Sun X (2017) Bexarotene protects against traumatic brain injury in mice partially through apolipoprotein E. Neuroscience 343:434–448
Sugo N, Hurn PD, Morahan MB, Hattori K, Traystman RJ, DeVries AC (2002) Social stress exacerbates focal cerebral ischemia in mice. Stroke 33:1660–1664
Bachmeier C, Beaulieu-Abdelahad D, Crawford F, Mullan M, Paris D (2013) Stimulation of the retinoid X receptor facilitates beta-amyloid clearance across the blood–brain barrier. J Mol Neurosci 49:270–276
Yang Y, Liu P, Chen L, Liu Z, Zhang H, Wang J, Sun X, Zhong W, Wang N, Tian K, Zhao J (2013) Therapeutic effect of Ginkgo biloba polysaccharide in rats with focal cerebral ischemia/reperfusion (I/R) injury. Carbohydr Polym 98:1383–1388
Sapkota A, Gaire BP, Cho KS, Jeon SJ, Kwon OW, Jang DS, Kim SY, Ryu JH, Choi JW (2017) Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation. PLoS One 12:e0171479
Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682–2688
Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW (1994) The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 11:187–196
He J, Liu H, Zhong J, Guo Z, Wu J, Zhang H, Huang Z, Jiang L, Li H, Zhang Z, Liu L, Wu Y, Qi L, Sun X, Cheng C (2018) Bexarotene protects against neurotoxicity partially through a PPARgamma-dependent mechanism in mice following traumatic brain injury. Neurobiol Dis 117:114–124
Luo Y, Kuang S, Li H, Ran D, Yang J (2017) cAMP/PKA-CREB-BDNF signaling pathway in hippocampus mediates cyclooxygenase 2-induced learning/memory deficits of rats subjected to chronic unpredictable mild stress. Oncotarget 8:35558–35572
Aronowski J, Strong R, Grotta JC (1997) Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab 17:1048–1056
Bomben V, Holth J, Reed J, Cramer P, Landreth G, Noebels J (2014) Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy. Neurobiol Aging 35:2091–2095
Rosell A, Agin V, Rahman M, Morancho A, Ali C, Koistinaho J, Wang X, Vivien D, Schwaninger M, Montaner J (2013) Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome? Transl Stroke Res 4:297–307
Pineiro R, Pendlebury ST, Smith S, Flitney D, Blamire AM, Styles P, Matthews PM (2000) Relating MRI changes to motor deficit after ischemic stroke by segmentation of functional motor pathways. Stroke 31:672–679
Thirugnanachandran T, Ma H, Singhal S, Slater LA, Davis SM, Donnan GA, Phan T (2018) Refining the ischemic penumbra with topography. Int J Stroke 13:277–284
Petralia RS, Mattson MP, Yao PJ (2014) Communication breakdown: the impact of ageing on synapse structure. Ageing Res Rev 14:31–42
Jin R, Liu L, Zhang S, Nanda A, Li G (2013) Role of inflammation and its mediators in acute ischemic stroke. J Cardiovasc Transl Res 6:834–851
Tachibana M, Shinohara M, Yamazaki Y, Liu CC, Rogers J, Bu G, Kanekiyo T (2016) Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1. Exp Neurol 277:1–9
Boehm-Cagan A, Michaelson DM (2014) Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene. J Neurosci 34:7293–7301
Fuentes D, Fernandez N, Garcia Y, Garcia T, Morales AR, Menendez R (2018) Age-related changes in the behavior of apolipoprotein E knockout mice. Behav Sci (Basel). https://doi.org/10.3390/bs8030033
Chen Y, Lomnitski L, Michaelson DM, Shohami E (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80:1255–1262
Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485:512–516
Mehan S, Meena H, Sharma D, Sankhla R (2011) JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J Mol Neurosci 43:376–390
Yang L, Liu CC, Zheng H, Kanekiyo T, Atagi Y, Jia L, Wang D, N'Songo A, Can D, Xu H, Chen XF, Bu G (2016) LRP1 modulates the microglial immune response via regulation of JNK and NF-kappaB signaling pathways. J Neuroinflammation 13:304
Wu Y, Pang J, Peng J, Cao F, Vitek MP, Li F, Jiang Y, Sun X (2016) An apoE-derived mimic peptide, COG1410, alleviates early brain injury via reducing apoptosis and neuroinflammation in a mouse model of subarachnoid hemorrhage. Neurosci Lett 627:92–99
Hoe HS, Harris DC, Rebeck GW (2005) Multiple pathways of apolipoprotein E signaling in primary neurons. J Neurochem 93:145–155
Liu B, Li F, Shi J, Yang D, Deng Y, Gong Q (2016) Gastrodin ameliorates subacute phase cerebral ischemiareperfusion injury by inhibiting inflammation and apoptosis in rats. Mol Med Rep 14:4144–4152
Liu G, Wang T, Wang T, Song J, Zhou Z (2013) Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep 1:861–867
Na KS, Park BC, Jang M, Cho S, Lee DH, Kang S, Lee CK, Bae KH, Park SG (2007) Protein disulfide isomerase is cleaved by caspase-3 and -7 during apoptosis. Mol Cells 24:261–267
Acknowledgements
This study was supported by research grants from the Chongqing Science Technology Commission of China (Grants Nos. cstc2015zdcy-ztzx120003, CSTC 2016jcyjA0268, and CSTC2018jcyjAX0821) and the Chongqing Municipal Health Bureau (Grant No. 2014-2-223).
Author information
Authors and Affiliations
Contributions
LX made a substantial contribution to the conception, design, and execution of the study. HL, JC, XH, RJ, QL, ZF, SW, QZ, YL, WD, and ZD participated in performing the experiments and carried out data analysis. HL participated in the performance of the study and writing the manuscript. All authors have read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liu, H., Liu, S., Tian, X. et al. Bexarotene Attenuates Focal Cerebral Ischemia–Reperfusion Injury via the Suppression of JNK/Caspase-3 Signaling Pathway. Neurochem Res 44, 2809–2820 (2019). https://doi.org/10.1007/s11064-019-02902-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-019-02902-5